den Brok, M.H.; de Roode, K.E.; Zijlmans, L.H.M.; Kleijn, L.H.J.; van Stevendaal, M.H.M.E.; Versteegen, R.M.; Wouters, L.W.M.; Rossin, R.; Robillard, M.S.
Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. Pharmaceuticals 2025, 18, 1380.
https://doi.org/10.3390/ph18091380
AMA Style
den Brok MH, de Roode KE, Zijlmans LHM, Kleijn LHJ, van Stevendaal MHME, Versteegen RM, Wouters LWM, Rossin R, Robillard MS.
Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. Pharmaceuticals. 2025; 18(9):1380.
https://doi.org/10.3390/ph18091380
Chicago/Turabian Style
den Brok, Martijn H., Kim E. de Roode, Luc H. M. Zijlmans, Laurens H. J. Kleijn, Marleen H. M. E. van Stevendaal, Ron M. Versteegen, Lieke W. M. Wouters, Raffaella Rossin, and Marc S. Robillard.
2025. "Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug" Pharmaceuticals 18, no. 9: 1380.
https://doi.org/10.3390/ph18091380
APA Style
den Brok, M. H., de Roode, K. E., Zijlmans, L. H. M., Kleijn, L. H. J., van Stevendaal, M. H. M. E., Versteegen, R. M., Wouters, L. W. M., Rossin, R., & Robillard, M. S.
(2025). Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. Pharmaceuticals, 18(9), 1380.
https://doi.org/10.3390/ph18091380